Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway

Prostate

Volumn 73, Issue 1, 2013, Pages 89-100

  Yu, Hsin Shan ^a   Lin, Tien Huang ^a,b   Tang, Chih Hsin ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Buddhist Tzu Chi General Hospital Taichung Branch   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

B2; BK; c Src; migration; PKC; prostate cancer

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ACTIN; BRADYKININ; BRADYKININ B2 RECEPTOR; GELATINASE B; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METALLOPROTEINASE; MUTANT PROTEIN; PROTEIN KINASE C DELTA; PROTEIN TYROSINE KINASE; ROTTLERIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ARTICLE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ACETOPHENONES; ADENOCARCINOMA; BENZOPYRANS; BRADYKININ; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C-DELTA; RECEPTOR, BRADYKININ B2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84870481545     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22544     Document Type: Article

References (42)

1. Robinson DR, Zylstra CR, Williams BO,. Wnt signaling and prostate cancer. Curr Drug Targets 2008; 9 (7): 571-580.
2. Van't Veer LJ, Weigelt B,. Road map to metastasis. Nat Med 2003; 9 (8): 999-1000. (Pubitemid 37021777)
3. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100 (1): 57-70. (Pubitemid 30046295)
4. Egeblad M, Werb Z,. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2 (3): 161-174. (Pubitemid 37328786)
5. Egeblad K, Baekgaard N,. Chronic venous insufficiency. Results of duplex scanning of 205 lower extremities with varices: 106 not previously operated and 99 previously operated for varicose veins. Ugeskr Laeger 2003; 165 (31): 3016-3018.
6. Tsai SH, Sheu MT, Liang YC, Cheng HT, Fang SS, Chen CH,. TGF-beta inhibits IL-1beta-activated PAR-2 expression through multiple pathways in human primary synovial cells. J Biomed Sci 2009; 16: 97.
7. Coussens LM, Werb Z,. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3 (11): 895-904. (Pubitemid 27017088)
8. Lokeshwar BL,. MMP inhibition in prostate cancer. Ann N Y Acad Sci 1999; 878: 271-289. (Pubitemid 29353576)
9. Deryugina EI, Quigley JP,. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25 (1): 9-34. (Pubitemid 43723979)
10. Proud D, Kaplan AP,. Kinin formation: Mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988; 6: 49-83. (Pubitemid 19141577)
11. Hall JM,. Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol Ther 1992; 56 (2): 131-190. (Pubitemid 23085319)
12. Regoli D, Barabe J,. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32 (1): 1-46.
13. Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, Hess JF,. Expression cloning of a human B1 bradykinin receptor. J Biol Chem 1994; 269 (34): 21583-21586. (Pubitemid 24274792)
14. Taub JS, Guo R, Leeb-Lundberg LM, Madden JF, Daaka Y,. Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res 2003; 63 (9): 2037-2041. (Pubitemid 36538604)
15. Zhao Y, Xue Y, Liu Y, Fu W, Jiang N, An P, Wang P, Yang Z, Wang Y,. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. Br J Neurosurg 2005; 19 (4): 322-326. (Pubitemid 43220790)
16. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, Muller-Esterl W, Maeda H,. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 2002; 98 (1): 29-35. (Pubitemid 34113414)
17. Enomoto K, Furuya K, Yamagishi S, Oka T, Maeno T,. Release of arachidonic acid via Ca2+ increase stimulated by pyrophosphonucleotides and bradykinin in mammary tumour cells. Cell Biochem Funct 1995; 13 (4): 279-286.
18. Ankorina-Stark I, Haxelmans S, Schlatter E,. Receptors for bradykinin and prostaglandin E2 coupled to Ca2+ signalling in rat cortical collecting duct. Cell Calcium 1997; 22 (4): 269-275. (Pubitemid 27490306)
19. Wiernas TK, Davis TL, Griffin BW, Sharif NA,. Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol 1998; 123 (6): 1127-1137. (Pubitemid 28120510)
20. Tang CH, Lu ME,. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 2009; 69 (16): 1781-1789.
21. Chiu YC, Huang TH, Fu WM, Yang RS, Tang CH,. Ultrasound stimulates MMP-13 expression through p38 and JNK pathway in osteoblasts. J Cell Physiol 2008; 215 (2): 356-365.
22. Hsieh MT, Hsieh CL, Lin LW, Wu CR, Huang GS,. Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. Life Sci 2003; 73 (8): 1007-1016. (Pubitemid 36734817)
23. Wang YC, Lee PJ, Shih CM, Chen HY, Lee CC, Chang YY, Hsu YT, Liang YJ, Wang LY, Han WH,. Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction. Anal Biochem 2003; 319 (2): 206-215.
24. Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, Yang HY, Wu HL,. Thrombomodulin-mediated cell adhesion: Involvement of its lectin-like domain. J Biol Chem 2003; 278 (47): 46750-46759.
25. Tseng CP, Huang CL, Huang CH, Cheng JC, Stern A, Tseng CH, Chiu DT,. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett 2003; 541 (1-3): 21-27. (Pubitemid 36428911)
26. Cheng CY, Kuo CT, Lin CC, Hsieh HL, Yang CM,. IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells. Br J Pharmacol 2010; 160 (7): 1595-1610.
27. Fong YC, Li TM, Wu CM, Hsu SF, Kao ST, Chen RJ, Lin CC, Liu SC, Wu CL, Tang CH,. BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway. J Cell Physiol 2008; 217 (3): 846-855.
28. Yang WH, Chang JT, Hsu SF, Li TM, Cho DY, Huang CY, Fong YC, Tang CH,. Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem 2010; 109 (1): 82-92.
29. Basu A, Adkins B, Basu C,. Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway. Cancer Res 2008; 68 (8): 2795-2802. (Pubitemid 351556278)
30. Hsieh HL, Sun CC, Wang TS, Yang CM,. PKC-delta/c-Src-mediated EGF receptor transactivation regulates thrombin-induced COX-2 expression and PGE(2) production in rat vascular smooth muscle cells. Biochim Biophys Acta 2008; 1783 (9): 1563-1575.
31. Roskoski R Jr., Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005; 331 (1): 1-14. (Pubitemid 40545134)
32. Huang CY, Yu HS, Lai TY, Yeh YL, Su CC, Hsu HH, Tsai FJ, Tsai CH, Wu HC, Tang CH,. Leptin increases motility and integrin up-regulation in human prostate cancer cells. J Cell Physiol 2011; 226 (5): 1274-1282.
33. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr., Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001; 276 (22): 18934-18940.
34. Mundy GR,. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2 (8): 584-593. (Pubitemid 37328925)
35. Hall JM,. Bradykinin receptors. Gen Pharmacol 1997; 28 (1): 1-6. (Pubitemid 27016051)
36. Scherer RL, McIntyre JO, Matrisian LM,. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 2008; 27 (4): 679-690.
37. Jeong JW, Jin CY, Park C, Han MH, Kim GY, Moon SK, Kim CG, Jeong YK, Kim WJ, Lee JD, Choi YH,. Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Int J Oncol 2012; 40 (5): 1697-1704.
38. Kim EJ, Hong JE, Lim SS, Kwon GT, Kim J, Kim JS, Lee KW, Park JH,. The hexane extract of Saussurea lappa and its active principle, dehydrocostus lactone, inhibit prostate cancer cell migration. J Med Food 2012; 15 (1): 24-32.
39. Berk BC, Taubman MB, Cragoe EJ Jr, Fenton JW II, Griendling KK,. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. J Biol Chem 1990; 265 (28): 17334-17340.
40. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA,. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 2004; 279 (29): 30175-30181. (Pubitemid 38937941)
41. Chen HT, Tsou HK, Tsai CH, Kuo CC, Chiang YK, Chang CH, Fong YC, Tang CH,. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway. J Cell Physiol 2010; 223 (3): 737-745.
42. Tung WH, Hsieh HL, Lee IT, Yang CM,. Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: Role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J Cell Biochem 2011; 112 (2): 559-570.